How should I manage a patient presenting with ventricular tachycardia?

Management of Ventricular Tachycardia

If the patient is hemodynamically unstable (hypotension, altered mental status, chest pain, pulmonary edema, or shock), perform immediate synchronized cardioversion without delay—this is the definitive first-line treatment and takes priority over all pharmacologic options. 1, 2

Initial Assessment: Determine Hemodynamic Stability

Assess for these specific signs of instability:

• Systolic blood pressure < 90 mmHg 2
• Altered mental status or loss of consciousness 1, 2
• Ongoing chest pain suggesting myocardial ischemia 2
• Signs of shock (cold extremities, poor perfusion) 2
• Acute heart failure manifestations (pulmonary edema, severe dyspnea) 2

If ANY of these are present, the patient is unstable—proceed directly to electrical cardioversion. 1, 2

Management of Unstable VT

Electrical Cardioversion Protocol

• Deliver synchronized cardioversion immediately without waiting for pharmacologic therapy 1, 2
• For monomorphic VT with rate >150 bpm: use 100 J synchronized shock as initial energy 1, 2
• For polymorphic VT resembling VF: use 200 J unsynchronized defibrillation 1, 2
• If first shock fails, escalate energy sequentially: 200 J → 300 J → 360 J 2
• Provide brief sedation before cardioversion if the patient is conscious and time permits 2
• If no defibrillator is immediately available, a precordial thump may be attempted in witnessed, monitored VT while equipment is prepared 1, 3

Management of Stable VT

First-Line Approach: Electrical Cardioversion

Even in hemodynamically stable patients, synchronized cardioversion remains the most effective first-line therapy and should be strongly considered before pharmacologic options. 1, 2 This is supported by Class I evidence from both the European Society of Cardiology and American College of Cardiology. 2

Pharmacologic Management (when cardioversion unavailable or deferred)

The choice of antiarrhythmic depends on the presence of heart failure, ischemia, or left ventricular dysfunction:

For patients WITHOUT heart failure, acute MI, or LV dysfunction (LVEF >40%):

• Intravenous procainamide is the preferred first-line agent (10 mg/kg at 50-100 mg/min over 10-20 minutes) 2
• Procainamide demonstrates the greatest efficacy for rhythm conversion among antiarrhythmics 2
• Alternative: IV flecainide may be considered 2

For patients WITH heart failure, suspected ischemia, or LVEF ≤40%:

• Intravenous amiodarone is preferred over procainamide due to better tolerability in these settings 1, 2, 3
• Dosing: 150 mg IV over 10 minutes, followed by maintenance infusion 1, 2
• Important caveat: Amiodarone has a slow onset (20-30 minutes) and is NOT ideal for rapid conversion 2
• Amiodarone is FDA-approved for hemodynamically unstable VT and frequently recurring VF 4

Second-Line Pharmacologic Options:

• Sotalol: May be considered for stable sustained monomorphic VT, including post-MI patients (1.5 mg/kg IV over 5 minutes) 1, 2
• Lidocaine: Only moderately effective and should be reserved as second-line when other agents are unsuitable 2, 3

Special VT Subtype: Left Ventricular Fascicular VT

• If the rhythm shows RBBB morphology with left axis deviation, this suggests LV fascicular VT 2
• For this specific subtype ONLY: IV verapamil or beta-blockers are safe and effective 2
• This is the ONLY scenario where calcium channel blockers are appropriate for VT 2

Critical Contraindications and Safety Pitfalls

NEVER Use Calcium Channel Blockers (Except Fascicular VT)

Calcium channel blockers (verapamil, diltiazem) are absolutely contraindicated for VT with structural heart disease—they can precipitate ventricular fibrillation and hemodynamic collapse. 1, 2, 3 This is a Class III (harmful) recommendation. 2

When Diagnosis is Uncertain

If you cannot definitively distinguish VT from SVT with aberrancy, always treat as VT. 1, 2 The risk of undertreating VT far exceeds the risk of treating SVT as VT. 2

Do not use adenosine for unstable or irregular/polymorphic wide-complex tachycardia. 1 Adenosine can precipitate VF in patients with coronary disease and rapid ventricular rates in pre-excited tachycardias. 1

Post-Conversion Management

Immediate Monitoring

• Monitor continuously for premature atrial or ventricular complexes immediately after cardioversion, as these can precipitate VT recurrence 2
• Maintain continuous ECG monitoring for at least 3 days 3

Pharmacologic Prevention of Recurrence

• If VT recurs after cardioversion, initiate antiarrhythmic therapy (procainamide or amiodarone) to prevent acute reinitiation 1, 2
• Beta-blockers are first-line for long-term prevention unless contraindicated, particularly post-MI 3
• Beta-blockers reduce recurrent VT/VF episodes requiring ICD intervention (HR 0.48, P=0.02) 3
• Combination of amiodarone plus beta-blocker significantly reduces ICD shocks compared to beta-blocker alone (HR 0.27, P<0.001) 3

Correct Underlying Causes

• Evaluate and correct ongoing myocardial ischemia 3
• Correct electrolyte abnormalities (maintain potassium in normal range) 3
• Address hypoxia and acid-base disturbances 3

Catheter Ablation Indications

Class I (Must Do):

• Urgent catheter ablation for scar-related heart disease with incessant VT or electrical storm 2, 3
• Ischemic heart disease with recurrent ICD shocks due to sustained VT 2, 3

Class IIa (Should Consider):

• After first episode of sustained VT in patients with ischemic heart disease who have an ICD 2, 3

ICD Implantation Criteria

Class I (Definitive Indication):

• Survivors of cardiac arrest with documented VT/VF not due to reversible cause 2
• Sustained VT with severe hemodynamic compromise (syncope, near-syncope, heart failure, shock, or angina) 2

Do NOT Implant ICD:

• VT/VF occurring within 48 hours of acute MI (transient/reversible cause) 2
• Incessant VT where ablation is preferred first 2
• Terminal illness with life expectancy <6 months 2

Common Clinical Pitfalls to Avoid

1. Delaying cardioversion in unstable patients while attempting pharmacologic conversion 3
2. Waiting for amiodarone to "work" after loading dose—if conversion hasn't occurred by 20-30 minutes, proceed directly to cardioversion 2
3. Using calcium channel blockers for wide-complex tachycardia unless absolutely certain of fascicular VT diagnosis 2
4. Inadequate post-conversion monitoring—recurrence is common and requires vigilance 3
5. Misidentifying accelerated idioventricular rhythm (ventricular rate <120 bpm) as true VT—this is usually a harmless reperfusion rhythm requiring no treatment 3